Herbomineral / bhasma category

Formulation class changes the questions you ask.

Patients remember the symptom. Classical prescribing remembers the formulation class. With plant products you ask which preparation, which exposure, which formulation. With herbominerals you immediately add questions about the mineral matrix, product quality, and the named recipe. That is a different evidence conversation, not a stronger version of the same tablet.

Evidence attaches to named rasaushadhis, not to "Ayurvedic tablet" as one category.

A large prescription audit across Ayurveda teaching hospitals ranked Arogyavardhini Vati, Punarnava Mandoor, Sutashekhar Rasa, and related rasaushadhis among the most frequently dispensed classical medicines. That pattern matches how often clinicians reach for herbomineral formulations.

Clinical trials study individual named products within the class: anemia work on Dhatri Lauha, pregnancy comparisons between lauha and mandoor vatis, metabolic and liver studies on specific vatis, and combination acidity regimens pairing plant churna with rasa. Evidence attaches to those named recipes. It does not validate "herbomineral medicine" as one interchangeable shelf word.

• Treating plant churna and herbomineral rasa as one safety class because both are "Ayurvedic"
• Assuming familiarity with one rasaushadhi transfers proof to another with a different mineral matrix
• Using prescribing frequency as category-wide evidence certainty
• Applying plant-only supplement logic to processed mineral formulations
• Skipping obstetric, pediatric, or hepatology review because the product is labeled herbal

The useful first question is "Plant churna, or herbomineral rasa?"

• Is this plant churna, herbomineral vati/rasa, or a proprietary OTC blend?
• What is the classical name on the label, not just the symptom it was given for?
• Pregnancy, pediatric use, kidney disease, or concurrent iron or mineral medicines?
• Who manufactured it, and is there a trustworthy quality standard behind the batch?
• What monitoring is planned if this continues beyond a short symptomatic trial?

Safety follows the matrix, not the "Ayurvedic tablet" habit alone.

Herbomineral matrices raise formulation-class questions about total mineral exposure, pregnancy risk, pediatric use, and product quality that differ from plant-only churnas. This page is category framing for counseling, not a guide to preparing or testing bhasma, and not a substitute for toxicology consultation when adulteration or unsupervised metal exposure is suspected.

When patients combine rasaushadhis with conventional medicines, iron salts, antacids, or other supplements, interaction and duplication review deserves explicit attention. Name the class first, then open the individual product entry for indication-specific evidence.